Skip to main content
Log in

Eliquis CPM updates regarding risk of haemorrhage

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. SSRIs = selective serotonin reuptake inhibitors; SNRIs = selective norepinephrine reuptake inhibitors

  2. including prevention of venous thromboembolism (VTE; including deep vein thrombosis [DVT] and pulmonary embolism [PE]) in adults undergoing elective knee or hip replacement; treatment of VTE; and continued prevention of recurrent DVT and PE.

Reference

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Eliquis CPM updates regarding risk of haemorrhage. Reactions Weekly 1757, 2 (2019). https://doi.org/10.1007/s40278-019-63230-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-63230-0

Navigation